Research Background

Pancreatic ductal adenocarcinoma (PDAC) is characterized by a complex tumor microenvironment in which interactions between cancer cells and surrounding stromal and immune cells can influence tumor development and progression.

Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has emerged as an important process in cancer biology. However, how cells within the tumor microenvironment influence the ferroptosis susceptibility of pancreatic cancer cells remains an important research question.

In this study, researchers identified a previously unrecognized role for resident tissue macrophages (RTMs): these macrophages transfer SELENOP to pancreatic cancer cells, providing selenium that supports cellular antioxidant defenses and protects tumor cells against ferroptosis.

Key Research Findings

1. Resident Tissue Macrophages Provide SELENOP to Pancreatic Cancer Cells

By integrating single-cell RNA sequencing, spatial transcriptomics, and lineage-tracing approaches, the researchers investigated cellular interactions within pancreatic tumors and identified resident tissue macrophages as an important source of SELENOP.

The findings indicate that macrophage-derived SELENOP can be transferred to neighboring pancreatic cancer cells, establishing a functional connection between the tumor microenvironment and tumor-cell selenium metabolism.

2. The SELENOP-LRP8 Pathway Supports Resistance to Ferroptosis

The study identified LRP8 as a receptor involved in SELENOP uptake by pancreatic cancer cells. Following uptake, SELENOP contributes to selenium availability and supports the activity of selenoprotein-based antioxidant systems.

These processes help limit lipid peroxidation and reduce ferroptotic cell death, particularly in mesenchymal-like pancreatic cancer cells. In experimental settings, recombinant SELENOP treatment was also used to investigate the relationship between SELENOP availability and ferroptosis sensitivity.

3. SELENOP Signaling Is Linked to Tumor Progression and Metastasis

Functional experiments, including disruption of Selenop in resident tissue macrophages and interference with Lrp8, demonstrated the contribution of this pathway to tumor-associated processes.

The study further connected macrophage-derived SELENOP signaling with epithelial-mesenchymal transition and pancreatic cancer progression. Analyses of human PDAC tissues provided additional evidence supporting the relevance of this macrophage-tumor cell interaction.

(J) Relative oxidized BODIPY 581/591 C11 levels in Zeb1^+/+ and Zeb1^-/- tumor cells untreated,treated with 5 nM RSL3 alone, or treated with 5 nM RSL3 + 0.5 μg/ml recombinant Selenopprotein . n = 3 – 4 per group .

Why This Study Matters

These findings expand the understanding of how the tumor microenvironment regulates cancer-cell survival. Rather than acting solely through direct cell-to-cell signaling, resident macrophages can influence tumor metabolism by supplying a functional protein that supports selenium-dependent antioxidant protection.

By connecting macrophage-derived SELENOP, LRP8-mediated uptake, selenium metabolism, and ferroptosis resistance, the study provides a framework for investigating the role of nutrient and protein transfer in pancreatic cancer biology.

The work also highlights the importance of studying interactions between immune cells and cancer cells when exploring mechanisms associated with tumor progression and therapeutic vulnerability.

Conclusion

This study uncovers a macrophage-mediated mechanism through which SELENOP transfer supports selenium-dependent antioxidant defense and protects pancreatic cancer cells from ferroptosis. The findings establish a connection between the tumor microenvironment, selenium metabolism, and cancer progression, offering new perspectives for research into ferroptosis regulation and pancreatic cancer biology.

AntibodySystem is pleased to see its Recombinant Mouse SELENOP Protein (Cat. No. YME73101) featured in this research published in Cell.